CIK 0001651308
- Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981209416
- Phone
- +41 616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-07-08 | OYLER JOHN Chief Executive Officer | Sale | −719 | $127.19 | $91K | 1,187 |
| 2019-07-08 | OYLER JOHN Chief Executive Officer | Sale | −1,087 | $127.89 | $139K | 100 |
| 2019-07-08 | OYLER JOHN Chief Executive Officer | Sale | −100 | $128.80 | $13K | 0 |
| 2019-07-01 | Wang Xiaodong Director | Sale | −2,200 | $126.13 | $277K | 2,647 |
| 2019-07-01 | Wang Xiaodong Director | Sale | −2,647 | $126.73 | $335K | 0 |
| 2019-06-27 | Huang Jane CMO, Hematology | Sale | −427 | $124.50 | $53K | 3 |
| 2019-06-27 | Huang Jane CMO, Hematology | Sale | −3 | $126.33 | $379 | 0 |
| 2019-06-27 | Liang Howard CFO & Chief Strategy Officer | Sale | −5,876 | $9.47 | $56K | 122,317 |
| 2019-06-17 | Yi Qingqing Director | Other disposition | −9,282 | 0 | ||
| 2019-06-06 | BAKER BROS. ADVISORS LP Director | Other disposition | −182,539 | 1,028,034 | ||
| 2019-06-06 | BAKER BROS. ADVISORS LP Director | Other acquisition | +13,516 | 20,618 | ||
| 2019-06-06 | BAKER BROS. ADVISORS LP Director | Other acquisition | +13,516 | 20,618 | ||
| 2019-06-06 | BAKER BROS. ADVISORS LP Director | Other disposition | −582,200 | 18,591 | ||
| 2019-06-06 | BAKER BROS. ADVISORS LP Director | Other acquisition | +43,109 | 43,109 | ||
| 2019-06-06 | BAKER BROS. ADVISORS LP Director | Other acquisition | +43,109 | 43,109 | ||
| 2019-06-05 | Yi Qingqing Director | Grant or award · Share Option (Right to Buy) | +64,610 | 64,610 | ||
| 2019-06-05 | Huang Jane CMO, Hematology | Grant or award | +62,842 | 334,463 | ||
| 2019-06-05 | Huang Jane CMO, Hematology | Grant or award · Share Option (Right to Buy) | +462,579 | 462,579 | ||
| 2019-06-05 | Wang Xiaodong Director | Grant or award · Share Option (Right to Buy) | +747,708 | 747,708 | ||
| 2019-06-05 | Liang Howard CFO & Chief Strategy Officer | Grant or award | +75,855 | 128,193 |
Page 101 of 123 · 2,455 trades